🔴 Circio Holding is trading 6% down today amid broad biotech weakness

Circio Holding is trading now at NOK 12.14, 6.04% down, primarily amid broad biotechnology weakness.

• The September 1 first-half update remained fundamentally positive, citing approximately NOK 620 million raised and funding through 2030.
• It also highlighted stronger preclinical results across its circular RNA platform.
• On September 2, XBI fell 4.24%, while profit-taking followed the sharp multi-session rally from NOK 8.53 on August 20 to NOK 13.20 on August 28.